Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Medical Crossfire®: Impact of COVID-19 on Neutropenia Management in Cancer Care and the Advent of Novel Treatment Approaches

Release Date: July 15, 2020
Expiration Date: July 15, 2021

Activity Overview

The current coronavirus disease 2019 (COVID-19) health crisis has posed several challenges for oncologists who are caring for immunocompromised patients. Neutropenia is a complication of anticancer therapy, and new guideline recommendations are available for its management in the context of the COVID-19 pandemic.

This online, on-demand virtual symposium brings together renowned experts for a discussion focused on addressing the latest advances in the management of neutropenia in cancer care, including current treatments, new approaches to management, and the challenges that the COVID-19 crisis has imposed on the care of patients with neutropenia. They will share patient case scenarios commonly encountered in clinical practice and will provide learners practical methods to optimize health outcomes for patients experiencing neutropenia in the oncology setting.

This educational activity is an archive of the live virtual symposium held on June 30, 2020.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward medical oncologists, hematologists, fellows, surgical oncologists and radiation oncologists interested in treatment and management of patients with cancer. Nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of cancer may also participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Determine patients with cancer at low-, intermediate-, and high-risk to develop neutropenia, including febrile neutropenia.
  • Discuss the impact of COVID-19 on neutropenia care for patients with cancer and updates made to current treatment guidelines in the context of management during the COVID-19 pandemic.
  • Discuss unmet gaps in the management of neutropenia and the role of emerging therapies to bridge those unmet clinical needs.
  • Create proactive management plans focused on pretreatment against neutropenia, and approaches to treat patients when neutropenia occurs.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Douglas W. Blayney, MD
Douglas W. Blayney, MD
Professor of Medicine, Oncology
Breast specialist
Stanford University Medical Center
Stanford, CA

Disclosures: Grant Research Support: BeyondSpring.

Pamela S. Becker, MD, PhD
Pamela S. Becker, MD, PhD
Professor of Medicine, Division of Hematology
University of Washington School of Medicine
Seattle, WA

Disclosures: Grant Research Support: AbbVie, Bristol Myers Squibb, Glycomimetics, JW Pharmaceutical, Novartis, Pfizer, Secura Bio, Tolero Pharmaceuticals, Trovagene; Consultant: Accordant Health Services (Caremark).

Gary H. Lyman, MD, MPH (Biostatistics), FASCO, FACP, FRCP
Gary H. Lyman, MD, MPH (Biostatistics), FASCO, FACP, FRCP
Professor, Public Health Sciences and Clinical Research
Fred Hutchinson Cancer Research Center
Professor of Medicine, Public Health and Pharmacy
University of Washington
Seattle, WA

Disclosures: Grant Research Support: Amgen grant to Fred Hutchinson Cancer Research Center.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By